US Stock MarketDetailed Quotes
CKPT Checkpoint Therapeutics
- 3.670
- -0.130-3.42%
Close Dec 13 16:00 ET
- 4.270
- +0.600+16.35%
Post 19:59 ET
179.22MMarket Cap-2.01P/E (TTM)
3.873High3.600Low2.26MVolume3.820Open3.800Pre Close8.80MTurnover6.19%Turnover RatioLossP/E (Static)48.83MShares4.50052wk High-14.22P/B134.09MFloat Cap1.36052wk Low--Dividend TTM36.54MShs Float105.000Historical High--Div YieldTTM7.20%Amplitude1.300Historical Low3.888Avg Price1Lot Size
Checkpoint Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 165.41%4.7M | -33.28%4.95M | 131.96%11.24M | -59.16%4.93M | -59.16%4.93M | -91.35%1.77M | -75.97%7.42M | -88.32%4.85M | -77.95%12.07M | -77.95%12.07M |
| -Cash and cash equivalents | 165.41%4.7M | -33.28%4.95M | 131.96%11.24M | -59.16%4.93M | -59.16%4.93M | -91.35%1.77M | -75.97%7.42M | -88.32%4.85M | -77.95%12.07M | -77.95%12.07M |
| Receivables | ---- | 32.26%41K | ---- | --0 | --0 | -35.42%31K | 72.22%31K | -32.69%35K | 329.41%73K | 329.41%73K |
| -Related party accounts receivable | ---- | 32.26%41K | ---- | --0 | --0 | -35.42%31K | 72.22%31K | -32.69%35K | 329.41%73K | 329.41%73K |
| Other current assets | 14.70%476K | -23.48%678K | -27.68%734K | -60.84%450K | -60.84%450K | -62.07%415K | -24.79%886K | -26.34%1.02M | 17.73%1.15M | 17.73%1.15M |
| Total current assets | 133.50%5.18M | -32.00%5.67M | 103.10%11.98M | -59.53%5.38M | -59.53%5.38M | -89.74%2.22M | -74.01%8.34M | -86.26%5.9M | -76.15%13.29M | -76.15%13.29M |
| Non current assets | ||||||||||
| Related parties assets | ---- | 32.26%41K | ---- | --0 | --0 | -35.42%31K | 72.22%31K | -32.69%35K | 329.41%73K | 329.41%73K |
| Total non current assets | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total assets | 133.50%5.18M | -32.00%5.67M | 103.10%11.98M | -59.53%5.38M | -59.53%5.38M | -89.74%2.22M | -74.01%8.34M | -86.26%5.9M | -76.15%13.29M | -76.15%13.29M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -9.57%10.12M | 32.30%14.29M | -5.29%15.45M | -24.00%9.97M | -24.00%9.97M | -22.94%11.19M | -23.18%10.8M | 46.00%16.31M | -24.75%13.12M | -24.75%13.12M |
| -accounts payable | -0.83%7.89M | 34.55%10.84M | -15.68%11.92M | -43.04%6.57M | -43.04%6.57M | -39.01%7.96M | -35.96%8.06M | 43.42%14.14M | -28.53%11.54M | -28.53%11.54M |
| -Due to related parties current | -30.24%2.01M | 29.60%3.18M | 58.89%2.94M | 115.54%2.82M | 115.54%2.82M | 159.23%2.88M | 118.04%2.45M | 82.36%1.85M | 22.86%1.31M | 22.86%1.31M |
| -Other payable | -37.54%223K | -7.67%265K | 82.76%583K | 110.79%586K | 110.79%586K | -3.25%357K | -17.77%287K | 7.41%319K | 19.31%278K | 19.31%278K |
| Current accrued expenses | -9.08%6.42M | -61.37%6.24M | -5.69%6.22M | -2.28%7.12M | -2.28%7.12M | -6.25%7.06M | 61.91%16.15M | -41.03%6.59M | -5.39%7.29M | -5.39%7.29M |
| Other current liabilities | -93.72%125K | -96.84%125K | -96.53%125K | -98.88%125K | -98.88%125K | --1.99M | --3.96M | --3.6M | --11.17M | --11.17M |
| Current liabilities | -16.42%17.77M | -32.24%21.42M | -20.84%22.23M | -43.78%18.43M | -43.78%18.43M | -7.38%21.26M | 28.38%31.61M | 23.73%28.08M | 26.14%32.77M | 26.14%32.77M |
| Non current liabilities | ||||||||||
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total liabilities | -16.42%17.77M | -32.24%21.42M | -20.84%22.23M | -43.78%18.43M | -43.78%18.43M | -7.38%21.26M | 28.38%31.61M | 23.73%28.08M | 26.14%32.77M | 26.14%32.77M |
| Shareholders'equity | ||||||||||
| Share capital | 150.00%5K | 100.00%4K | 300.00%4K | 200.00%3K | 200.00%3K | -80.00%2K | -77.78%2K | -88.89%1K | 0.00%1K | 0.00%1K |
| -common stock | 150.00%5K | 100.00%4K | 300.00%4K | 200.00%3K | 200.00%3K | -80.00%2K | -77.78%2K | -88.89%1K | 0.00%1K | 0.00%1K |
| Retained earnings | -15.74%-341.67M | -14.67%-331.95M | -19.17%-325.28M | -19.75%-314.33M | -19.75%-314.33M | -22.26%-295.21M | -25.40%-289.48M | -25.96%-272.96M | -31.33%-262.49M | -31.33%-262.49M |
| Paid-in capital | 19.16%329.08M | 18.78%316.2M | 24.25%311.61M | 23.54%297.86M | 23.54%297.86M | 15.01%276.16M | 11.71%266.21M | 5.85%250.78M | 8.12%241.12M | 8.12%241.12M |
| Other equity interest | ---- | ---- | --3.42M | 81.38%3.42M | 81.38%3.42M | ---- | ---- | ---- | -71.43%1.89M | -71.43%1.89M |
| Total stockholders'equity | 33.89%-12.59M | 32.32%-15.75M | 53.79%-10.25M | 33.03%-13.05M | 33.03%-13.05M | -1,326.44%-19.04M | -411.85%-23.27M | -209.71%-22.18M | -165.50%-19.48M | -165.50%-19.48M |
| Total equity | 33.89%-12.59M | 32.32%-15.75M | 53.79%-10.25M | 33.03%-13.05M | 33.03%-13.05M | -1,326.44%-19.04M | -411.85%-23.27M | -209.71%-22.18M | -165.50%-19.48M | -165.50%-19.48M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data